Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_815c016d95c536f756c63133972943fb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16052 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-705 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-079 |
filingDate |
2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78992d10685c6942fb16cc19d536f0f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e754103e0e2ce59f07a8137035b87e4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83451f8db5bcfce7c3799c2be5ec2abb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0ea4247d8de38fd5fa0d134d46f2ba7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90367370c1e2cf8a50f4541e8baa5f58 |
publicationDate |
2016-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016017284-A1 |
titleOfInvention |
Cyprinid herpesvirus ii-sensitive brain tissue cell line of carassius auratus gibelio and establishing method and use thereof |
abstract |
The present invention discloses a cyprinid herpesvirus II-sensitive brain tissue cell line of Carassius auratus gibelio and establishing method and use thereof. The cell line is deposited in China Center for Type Culture Collection under an accession number of CCTCC No: C2013179. The brain tissue cell line of Carassius auratus gibelio is in good growth state and sensitive to CyHV-2 that is presently hardly cultured with ordinary fish cell lines. After six passages of CyHV-2 in GiCB cells, viral nucleic acid can still be detected and a cytopathic effect is stable. When ultrathin microscopic sections are prepared from cells having the cytopathic effect, considerable mature CyHV-2 virions and their replication process can be observed in GiCB cells. The construction method of the brain tissue cell line of Carassius auratus gibelio of the present invention has high repeatability, scientific and reasonable conditions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109329128-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110564750-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108546672-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110893235-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110305844-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115960903-A |
priorityDate |
2013-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |